Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies ; volume:13 ; number:1 ; day:5 ; month:3 ; year:2024 ; pages:1-5 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (5.3.2024), 1-5, 12.2024
- Urheber
-
Wang, Linqin
Lv, Yuqi
Zhou, Linghui
Wu, Shenghao
Zhu, Yuanyuan
Fu, Shan
Ding, Shuyi
Hong, Ruimin
Zhang, Mingming
Yu, Hanjing
Chang, Alex H.
Wei, Guoqing
Hu, Yongxian
Huang, He
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00495-6
- URN
-
urn:nbn:de:101:1-2405101110228.433808535780
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Linqin
- Lv, Yuqi
- Zhou, Linghui
- Wu, Shenghao
- Zhu, Yuanyuan
- Fu, Shan
- Ding, Shuyi
- Hong, Ruimin
- Zhang, Mingming
- Yu, Hanjing
- Chang, Alex H.
- Wei, Guoqing
- Hu, Yongxian
- Huang, He
- SpringerLink (Online service)
Ähnliche Objekte (12)
Special issue: CAR‐T cell therapy for hematological malignancies
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Cytokine release syndrome
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Cytokine release syndrome
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
Special issue: CAR‐T cell therapy for hematological malignancies
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Cytokine release syndrome
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies